Metraipolis › archive › dc_dc37bcb8e2aa

Recent advances in preclinical studies combining hyperthermia therapy with novel immune checkpoint targeting agents — Europe PMC PMID:41948319

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41948319
DOI
10.3389/fimmu.2026.1722115
License (as archived)
solo-consultazione
Archived
2026-11-04T01:40:33.783Z
SHA-256 of the archived text
fa858a33470a098784089b82613f480c8383f583ef496fc7a4ac633173e07f94
Stable URL of this page
https://metraipolis.com/documento/dc_dc37bcb8e2aa

How to cite

Recent advances in preclinical studies combining hyperthermia therapy with novel immune checkpoint targeting agents — Europe PMC PMID:41948319 — Europe PMC (en), https://europepmc.org/article/MED/41948319 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dc37bcb8e2aa (Metraipolis archive dc_dc37bcb8e2aa, sha256 fa858a33470a098784089b82613f480c8383f583ef496fc7a4ac633173e07f94)
BibTeX
@misc{dcdc37bcb8e2aa,
  title = {Recent advances in preclinical studies combining hyperthermia therapy with novel immune checkpoint targeting agents — Europe PMC PMID:41948319},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41948319},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dc37bcb8e2aa; sha256 fa858a33470a098784089b82613f480c8383f583ef496fc7a4ac633173e07f94},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41948319. Agents can read the archived copy with the MCP tool read_document.